PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU4WSV2

Market Closed - Deutsche Boerse AG 18:43:50 24/05/2024 BST
11.19 EUR -6.59% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+1.53%
1 month+4.36%
Date Price Change
24/05/24 11.19 -6.59%
23/05/24 11.98 +4.17%
22/05/24 11.5 +8.80%
21/05/24 10.57 +8.86%
20/05/24 9.71 -1.62%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 06:43 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU4WSV
ISINDE000VU4WSV2
Date issued 16/03/2023
Strike 50.06
Maturity Unlimited
Parity 1 : 1
Emission price 16.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 20.15
Lowest since issue 1.76

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus